Inogen (INGN) Shares Outstanding (2012 - 2026)
Inogen (INGN) posted quarterly Shares Outstanding (Entity) of $27.4 million for Q1 2026, up 1.78% year-over-year from $26.9 million in Q1 2025, and little changed quarter-over-quarter from $27.2 million in Q4 2025.
Inogen (INGN) Shares Outstanding (2012 - 2026) Analysis & Trends
Inogen (INGN) has reported Shares Outstanding (Entity) for 15 consecutive years, with $27.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 1.78% year-over-year to $27.4 million; the TTM figure through Mar 2026 stood at $27.4 million (up 1.78% YoY), while the FY2025 annual figure was $27.2 million, up 13.93% from the prior year.
- Shares Outstanding (Entity) steadied at $27.4 million in Q1 2026 per INGN's latest filing, from $27.2 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $27.4 million in Q1 2026 and bottomed at $22.8 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $24.4 million across 5 years, with a median of $23.5 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) grew 0.87% — and 2025, when it climbed 14.19%.
- Inogen's Shares Outstanding (Entity) stood at $22.9 million in 2022, then gained by 1.67% to $23.3 million in 2023, then grew by 2.48% to $23.9 million in 2024, then advanced by 13.93% to $27.2 million in 2025, then grew by 0.49% to $27.4 million in 2026.
- Business Quant data shows INGN's Shares Outstanding (Entity) at $27.4 million in Q1 2026, $27.2 million in Q4 2025, and $27.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Inogen | 152.53 Mn | 47.00 Mn | 43.27 Mn | 27.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.05 Mn |
| Mar 31, 2026 | 27.32 Mn |
| Dec 31, 2025 | 26.60 Mn |
| Sep 30, 2025 | 27.08 Mn |
| Jun 30, 2025 | 26.96 Mn |
| Mar 31, 2025 | 25.16 Mn |
| Dec 31, 2024 | 23.65 Mn |
| Sep 30, 2024 | 23.75 Mn |
| Jun 30, 2024 | 23.61 Mn |
| Mar 31, 2024 | 23.40 Mn |
| Dec 31, 2023 | 23.18 Mn |
| Sep 30, 2023 | 23.23 Mn |
| Jun 30, 2023 | 23.15 Mn |
| Mar 31, 2023 | 23.01 Mn |
| Dec 31, 2022 | 22.85 Mn |
| Sep 30, 2022 | 22.88 Mn |
| Jun 30, 2022 | 22.85 Mn |
| Mar 31, 2022 | 22.75 Mn |
| Dec 31, 2021 | 22.49 Mn |
| Sep 30, 2021 | 22.62 Mn |